samo d/acc

Crypto class '17 - prev SM &Comm Lead Humanity Protocol 🤝Community Collabs @gmoneyNFT - 💬 CM @nftnow - 🫂 Community @justinaversano

[samo d/acc @samoweb3]

https://t.co/DvVBX1SqJJ

[samo d/acc @samoweb3]

@og_miracles

[samo d/acc @samoweb3]

Time for some of that WAGMI feeling, fam

Stay healthy ☀️🌻

[samo d/acc @samoweb3]

@gregisenberg Sounds like a new, different product. Build it, Greg! 🔥

[samo d/acc @samoweb3]

New day working with AI 😅

[stolen from @DataChaz on LinkedIn]

[samo d/acc @samoweb3]

Happy Children's Day, kid! 🎈

[samo d/acc @samoweb3]

@_ZaricX I mean, this works decent for me rn. who knows in 1 month? 😅

[samo d/acc @samoweb3]

Absolutely!

MODEL << FEATURES + PACKAGING

PS still struggling to work multi-device, multi-project with Claude Code; what works for me rn:
➡️ VSC (for easy file access) + CC CLI
➡️ tmux sessions - to attach/detach from any device

[GREG ISENBERG @gregisenberg]

I didn't cover Claude Opus 4.8 on my pod because I don't think it's MEANINGFULLY better than GPT 5.5 as of May 29th.

We're entering the era where model releases start to feel like iPhone releases. Remember when every new iPhone was a genuine leap? Now it's a slightly better camera and you can't really tell the difference. That's where models are heading. 4.6 to 4.7 to 4.8. Each one is a little different. Nobody can agree if it's better or worse. The benchmarks say one thing, the vibes say another.

The thing that actually matters right now is what's happening around the models. Claude Code shipped dynamic workflows this same week and that genuinely changes what one person can build.

Codex shipped a desktop app with an in app browser that combines coding and knowledge work in one surface. Those are the releases that move the needle for people. The model underneath is becoming interchangeable.

I think we're maybe 6 months from nobody caring which model they're using the way nobody cares which engine is in their Uber. You just want to get where you're going.

When something genuinely changes the game for builders, I'll cover it on @startupideaspod. Opus 4.8 wasn't that. Dynamic workflows was.

I'd rather save you the hour.

[samo d/acc @samoweb3]

@rileybrown @AnthropicAI Didn't use cowork too much, tbh I don't use the Claude app most of the time.

So can't comment on the app buttons/features.

[samo d/acc @samoweb3]

@Teknium hey @Teknium,
how do you manage shorter run processes - like searching for data or similar?

feels like a waste of resources (time+tokens) to run quick research with my default 90 iterations

ty 🙏💚

[samo d/acc @samoweb3]

@intelliot @joshgonsalves_ then it also needs to be compared in the same “loop” / flow / process

[samo d/acc @samoweb3]

@brian_lovin install caveman skill/plugin

saves tokens AND speaks simple/fast

[samo d/acc @samoweb3]

@garrytan great, but seems to early to draw a conclusion now

OpenClaw is also fucking awesome when you install it
2 weeks later, not so much 😅
2 months later you wanna kill the mfer 😭

[samo d/acc @samoweb3]

i’m already beyond annoyed with this type of post

Starting now I’m blocking every BREAKING post I’m seeing about a new LLM launch

FU VERY MUCH

[samo d/acc @samoweb3]

@nelsonlopes_ @steipete @openclaw also… skipping THE instructions

[samo d/acc @samoweb3]

@nelsonlopes_ @steipete @openclaw it is because
1. the product: needs constant tinkering, it’s not a “install it and work” thing
2. the user: the over-optimizing/automating cycle ia real 😅

[samo d/acc @samoweb3]

@betty_nft give it a bit. wasn’t the same with SuperRare? 😅

[samo d/acc @samoweb3]

@ryancarson I think ppl are overestimating the differences between models

Switching back/forth adds too much complexity & costs

[samo d/acc @samoweb3]

99% of making sure in 2026 you're going to live a long, healthy life is just:

➡️ don't die
➡️ wait for technology to find solutions to your problems

That first point makes all the difference. Bullish TECH

[Afshine Emrani MD FACC @afshineemrani]

1/5
I'm a cardiologist. I have spent twenty years watching cholesterol destroy arteries, trigger heart attacks, and kill people I care about.
Today, Eli Lilly presented data that may begin to end that era.
VERVE-102. A single infusion. One dose. It uses base editing to permanently turn off the PCSK9 gene in your liver.
Presented today at the European Atherosclerosis Society Congress:
88% reduction in PCSK9.
62% reduction in LDL cholesterol.
Sustained up to 18 months.
No treatment-related serious adverse events.
One infusion. Not daily pills you forget to take. Not monthly injections. One dose — and your cholesterol may stay low for the rest of your life.